Skip to main content

Clinical trial IJB-LBC-NEOCHECKRAY-2018

Neo-adjuvant chemotherapy combined with SBRT to the primary tumor +/- durvalumab +/- oleclumab in luminal B breast cancer: a phase ll randomized trial

Organ Breast
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor Institut Jules Bordet
EudraCT Identifier 2018-004165-13
Inclusion criteria No contraindication for immunotherapy
Last update